Single-cell heterogeneity of EGFR and CDK4 co-amplification is linked to immune infiltration in glioblastoma
Walentynowicz, Kacper A., Engelhardt, Dalit, Cristea, Simona, Yadav, Shreya, Onubogu, Ugoma, Salatino, Roberto, Maerken, Melanie, Vincentelli, Cristina, Jhaveri, Aashna, Geisberg, Jacob, McDonald, Thomas O., Michor, Franziska, Janiszewska, Michalina
Published in Cell reports (Cambridge) (28.03.2023)
Published in Cell reports (Cambridge) (28.03.2023)
Get full text
Journal Article
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial
Parra, Edwin Roger, Zhang, Jiexin, Duose, Dzifa Yawa, Gonzalez-Kozlova, Edgar, Redman, Mary W, Chen, Hong, Manyam, Ganiraju C, Kumar, Gayatri, Zhang, Jianhua, Song, Xingzhi, Lazcano, Rossana, Marques-Piubelli, Mario L, Laberiano-Fernandez, Caddie, Rojas, Frank, Zhang, Baili, Taing, Len, Jhaveri, Aashna, Geisberg, Jacob, Altreuter, Jennifer, Michor, Franziska, Provencher, James, Yu, Joyce, Cerami, Ethan, Moravec, Radim, Kannan, Kasthuri, Luthra, Rajyalakshmi, Alatrash, Gheath, Huang, Hsin-Hui, Xie, Hui, Patel, Manishkumar, Nie, Kai, Harris, Jocelyn, Argueta, Kimberly, Lindsay, James, Biswas, Roshni, Van Nostrand, Stephen, Kim-Schulze, Seunghee, Gray, Jhanelle E, Herbst, Roy S, Wistuba, Ignacio I, Gettinger, Scott, Kelly, Karen, Bazhenova, Lyudmila, Gnjatic, Sacha, Lee, J Jack, Zhang, Jianjun, Haymaker, Cara
Published in Clinical cancer research (15.04.2024)
Published in Clinical cancer research (15.04.2024)
Get full text
Journal Article
Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer
Dilly, Julien, Hoffman, Megan T, Abbassi, Laleh, Li, Ziyue, Paradiso, Francesca, Parent, Brendan D, Hennessey, Connor J, Jordan, Alexander C, Morgado, Micaela, Dasgupta, Shatavisha, Uribe, Giselle A, Yang, Annan, Kapner, Kevin S, Hambitzer, Felix P, Qiang, Li, Feng, Hanrong, Geisberg, Jacob, Wang, Junning, Evans, Kyle E, Lyu, Hengyu, Schalck, Aislyn, Feng, Ningping, Lopez, Anastasia M, Bristow, Christopher A, Kim, Michael P, Rajapakshe, Kimal I, Bahrambeigi, Vahid, Roth, Jennifer A, Garg, Kavita, Guerrero, Paola A, Stanger, Ben Z, Cristea, Simona, Lowe, Scott W, Baslan, Timour, Van Allen, Eliezer M, Mancias, Joseph D, Chan, Emily, Anderson, Abraham, Katlinskaya, Yuliya V, Shalek, Alex K, Hong, David S, Pant, Shubham, Hallin, Jill, Anderes, Kenna, Olson, Peter, Heffernan, Timothy P, Chugh, Seema, Christensen, James G, Maitra, Anirban, Wolpin, Brian M, Raghavan, Srivatsan, Nowak, Jonathan A, Winter, Peter S, Dougan, Stephanie K, Aguirre, Andrew J
Published in Cancer discovery (08.07.2024)
Published in Cancer discovery (08.07.2024)
Get full text
Journal Article
Abstract PR08: Intratumoral heterogeneity drives resistance to Antibody Drug Conjugate therapy: Analysis of the NeoSTAR trial of neoadjuvant Sacituzumab govitecan for localized TNBC
Spring, Laura M., Wu, Bogang, Liu, Ting, Geisberg, Jacob, Cristea, Simona, Bossuyt, Veerle, Abelman, Rachel Occhiogrosso, Peiris, Nicole, Coates, James, Koh, Siang-Boon, Zhang, Mengran, Ryan, Lianne, Moy, Beverly, Isakoff, Steven J., Tolaney, Sara M., Michor, Franziska, Bardia, Aditya, Ellisen, Leif W.
Published in Cancer research (Chicago, Ill.) (01.02.2024)
Published in Cancer research (Chicago, Ill.) (01.02.2024)
Get full text
Journal Article